damien eggenspieler

Damien Eggenspieler is the Healthcare Program Director at SYSNAV, where they lead the healthcare department focusing on developing the first digital outcome platform approved by the European Medicines Agency in neuroscience. Previously, Damien has held various roles, including Head of Strategy and Franchise Operations at Merck KGaA and Chief Operating Officer at Cubyn. They earned a Master of Science in Mechanical Engineering from the Massachusetts Institute of Technology and a diplôme d'ingénieur from Ecole Polytechnique. Additionally, Damien has experience as a consultant at McKinsey & Company and as a founder of Solitonik.